Gardner D. M., Murphy A. L., Kutcher S., Beaulieu S., Carandang C., Labelle A., Lalonde P., Malla A., Milliken H., O'Donovan C., Schaffer A., Soni J., Taylor V. H., Williams R. (2013). Evidence review and clinical guidance for the use of ziprasidone in Canada, Ann Gen Psychiatry, 12(1), 1. Find out more.

Parikh S. V., Hawke L. D., Zaretsky A., Beaulieu S., Patelis-Siotis I., Macqueen G., Young L. T., Yatham L., Velyvis V., Belanger C., Poirier N., Enright J., Cervantes P. (2013). Psychosocial interventions for bipolar disorder and coping style modification: similar clinical outcomes, similar mechanisms?, Can J Psychiatry, 58(8), 482-6. Find out more.

Schaffer A., Parikh S. V., Kennedy S. H., Milev R., Frey B. N., Goldstein B. I., Beaulieu S., Alda M., O'Donovan C., MacQueen G., McIntyre R. S., Sharma V., Ravindran A., Young L. T., Bond D. J., Lam R. W., Yatham L. N. (2013). Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelines, Bipolar Disord, 15(3), 338-9. Find out more.

Yatham L. N., Kennedy S. H., Parikh S. V., Schaffer A., Beaulieu S., Alda M., O'Donovan C., Macqueen G., McIntyre R. S., Sharma V., Ravindran A., Young L. T., Milev R., Bond D. J., Frey B. N., Goldstein B. I. (2013). The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future, Bipolar Disord, 15(1), 58-60. Find out more.

Yatham L. N., Kennedy S. H., Parikh S. V., Schaffer A., Beaulieu S., Alda M., O'Donovan C., Macqueen G., McIntyre R. S., Sharma V., Ravindran A., Young L. T., Milev R., Bond D. J., Frey B. N., Goldstein B. I., Lafer B., Birmaher B., Ha K., Nolen W. A., Berk M. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disord, 15(1), 1-44. Find out more.